News Briefs

IconOVir Bio snags $77m Series A

IconOVir Bio Inc., a preclinical-stage biotechnology company, has raised $77 million in Series A financing.

5 January 2021

IconOVir Bio Inc., a preclinical-stage biotechnology company, has raised $77 million in Series A financing. Nextech and Vida Ventures led the round.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now